Medicon Valley Biomedical Newsletter
The Medicon Valley Biomedical Newsletter is intended for decision makers in pharmaceutical and biotech companies, investors and other professionals who wish to keep updated on business related activities in the Medicon Valley.
October
Medicon Valley Biomedical Newsletter October edition is brought to you by Region Skåne and Copenhagen Capacity
Our top stories are from Lund University where Felix Mitrelmann has received this year's Fernström award, and a new centre of Excellence has been established with focus on diabetes. Diabets and cancer are strong research areas in Medicon Valley in the universities as well as in the private sector.Find more information on this story and other top news from Medicon Valley in the newsletter below.
Other news from the region are continuously updated on our webpage: www.mediconvalley.com/NewsAndEvents/News
-
Scientist at Lund University Wins Nordic Fernström Prize
17 Oct 2007
The Eric K. Fernström Foundation has announced Felix Mitelman the winner of the Foundation's Nordic Prize. Mitelman receives first prize EUR 110000. Felix Mitelman is Professor of clinical ...
-
New Anti-Diabetic Food Centre at Lund University
5 Oct 2007
At Lund University a new multidisciplinary research facility, Anti-Diabetic Food Centre, has opened. The research at the new centre will focus on the correlation between the intestine's ecosystem ...
-
Bavarian Nordic and the U.S. Government Extends RFP-2 Contract
3 Oct 2007
The U.S. government has extended the RFP-2 contract that was awarded to Bavarian Nordic A/S in 2004. Within the scope of the extension, Bavarian Nordic will initiate a larger Phase II study with IMVAM...
-
Exiqon Signs a Cooperative Research and Development Agreement with NCI
17 Oct 2007
Exiqon A/S has penned a Cooperative Research and Development Agreement with the National Cancer Institute, NCI to develop microRNA-based diagnostics for colon cancer. Specifically, the alliance...
-
TopoTarget and Lundbeck Sign Agreement for Siramesine
5 Oct 2007
TopoTarget A/S and Lundbeck A/S have announced an agreement for the development of siramesine for the treatment of cancer. Siramesine has shown strong results in preclinical studies carried out by the...
Medicon Valley Biomedical Newsletter is published by
Region Skåne and Copenhagen Capacity.
We assist foreign companies in finding locations and partnerships in Medicon Valley. We offer free assistance at each step of the business development phase. Visit www.mediconvalley.com or contact us to learn more about the opportunities that await your company in Medicon Valley.
|
Copenhagen Capacity |
Region Skåne |
If you have any comments on the Medicon Valley Biomedical Newsletter please contact the editor at info@mediconvalley.com.
Here you can subscribe to the Medicon Valley Academy Newsletter
The MVA newsletter is an e-mail news service for Medicon Valley Academy (MVA) members and other actors within life science. The newsletter brings you information on new MVA initiatives and activities, editorials on issues of topical interest, news from the region together with available jobs and relevant life science events.
Click here to subscribe or visit www.mva.org.
